More than half of the population of the countries of the Organization for Economic Cooperation and Development (OECD) was overweight or obese, according to the latest...
The gross margin of 64.9% has also been in line with expectations, reflecting the impact of the high cost of production goods and inflation that has...
Rovi announced that it estimates its operating income will decrease by around 10% compared to 2023. This forecast has been justified, mainly, by the fact that...
The Barometer of Health Companies in Spain is an annual report that aims to be a useful tool for professionals in the sector when making strategic...
PharmaMar is a biopharmaceutical company based in Madrid, specializing in the discovery, development, and commercialization of new antitumor drugs of marine origin. The company has a...
Fresenius Kabi is a global healthcare company specializing in medicines and technologies for infusion, transfusion, and clinical nutrition. Its products and services are used to care...
This week the Catalan pharmaceutical company announced an annual growth of 22% in its income until the third quarter of 2023, which amounted to €237 million....
Grifols is a listed Catalan pharmaceutical company. The company's activity focuses on the research, development, manufacturing, and marketing of products derived from plasma (blood products), intravenous therapy...
As part of the transaction, Galapagos will also transfer to Alfasigma the European and U.K. marketing authorizations and related commercial, medical, and development activities, as well...
In short, the watch launched by Durcal acts as a solution for elderly people who live alone and are not considering moving to a residence. In...